MARKET

ZOM

ZOM

Zomedica Corp
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6278
-0.0007
-0.11%
After Hours: 0.6350 +0.0072 +1.15% 19:59 07/23 EDT
OPEN
0.6321
PREV CLOSE
0.6285
HIGH
0.6321
LOW
0.6080
VOLUME
8.74M
TURNOVER
--
52 WEEK HIGH
2.910
52 WEEK LOW
0.0628
MARKET CAP
613.87M
P/E (TTM)
-13.8282
1D
5D
1M
3M
1Y
5Y
Zomedica Is Still Working Out How to Sell Truforma. Can Investors Afford to Wait?
Investor Place · 3d ago
Ignore Zomedica’s Recent Struggles. The Road Ahead Remains Bright.
Investor Place · 5d ago
Speculative Investors Are Crazy Not to Buy Zomedica at Its Current Prices
Investor Place · 07/15 13:21
Wait for Zomedica to Give Up More of its Meme Stock Gains
Investor Place · 07/15 12:40
Zomedica Stock Still Has a Rocky Few Months Left Ahead of It
Investor Place · 07/14 10:00
BRIEF-Zomedica Provides Corporate Update
reuters.com · 07/06 10:07
Zomedica Provides Corporate Update
FOCUSED ON TRUFORMA® INSTRUMENT PLACEMENTS AND BUILDING DIRECT SALES ORGANIZATION ANN ARBOR, Mich., July 06, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diag...
GlobeNewswire · 07/06 10:05
Zomedica vs. Phibro Animal Health: Which Pet Stock is a Better Buy?
StockNews.com · 07/01 10:50
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ZOM. Analyze the recent business situations of Zomedica Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ZOM stock price target is 1.200 with a high estimate of 1.200 and a low estimate of 1.200.
EPS
Institutional Holdings
Institutions: 30
Institutional Holdings: 14.30M
% Owned: 1.46%
Shares Outstanding: 977.81M
TypeInstitutionsShares
Increased
10
618.54K
New
6
747.38K
Decreased
7
136.68K
Sold Out
15
2.83M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.97%
Pharmaceuticals & Medical Research
+0.92%
Key Executives
Chairman/Director
Jeffrey Rowe
President/Chief Operating Officer
Stephanie Morley
Chief Executive Officer/Director
Robert Cohen
Chief Financial Officer/Secretary
Ann Cotter
Executive Director/Other
William MacArthur
Other
Andrea Eberle
Other
Angy Guerrant
Other
Bruk Herbst
Other
Angie Moricz
Director
Christopher Wolfenberg
Independent Director
Jane Eagleson
Independent Director
Christopher MacLeod
Independent Director
Johnny Powers
Independent Director
Thomas Robitaille
Independent Director
Rodney Williams
No Data
About ZOM
Zomedica Corp., formerly Zomedica Pharmaceuticals Corp., is a development stage veterinary diagnostic and pharmaceutical company. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. It is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. It is developing ZM-017 as a canine cancer liquid biopsy platform.

Webull offers kinds of Zomedica Corp stock information, including AMEX:ZOM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZOM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZOM stock methods without spending real money on the virtual paper trading platform.